About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Relief from Allergic Rhinitis Symptoms Via New Nasal Spray

by Rajashri on June 19, 2009 at 7:50 PM
Font : A-A+

 Relief from Allergic Rhinitis Symptoms Via New Nasal Spray

Researchers have revealed that a new all-natural nasal spray, called MucoAd, can be safe and effective in relieving symptoms of allergic rhinitis.

MucoAd is a mucoadhesive molecule (hypromellose) that prolongs contact with the nasal surface so that the nasal spray remains well tolerated, lasts longer, and reduces the frequency of repeat dosing.

Advertisement

Researchers from Strategic BioSciences, together with investigators from the Institute for Asthma and Allergy (Wheaton, MD), conducted the double blind cross-over study.

The study included 24 patients suffering from symptomatic, persistent allergic rhinitis who recorded the severity of their runny nose, itchy nose, stuffy nose and sneezing twice a day for a month.
Advertisement

The researchers compared the capsaicin- MucoAd formula (Sinol-M) to the 1st generation product without MucoAd (Sinol).

They found that capsaicin nasal spray reduced all symptoms, and symptom relief was achieved with less Sinol-M than Sinol, particularly at night.

This suggested that Sinol-M might permit a better night's sleep, free from rhinitis symptoms.

There were no treatment related adverse events during the study and Sinol-M was associated with less subjective reports of discomfort.

"This study represents the first-ever capsaicin-based treatment for allergic rhinitis to be supported by prospective clinical data, and has important implications for millions of Americans who suffer from nasal allergies. This all-natural product has now been demonstrated to provide clinical effectiveness without any of the side effects associated with intra-nasal steroids and is available without a prescription," said Dr. Michael A. Kaliner, of the Institute of Asthma and Allergy, Wheaton, Maryland, and principal author and presenter of this poster.

He added: "It may also provide a new option for patients looking for a zinc-free, all-natural product in the wake of the June 16, 2009 Food and Drug Administration (FDA) warning to consumers to stop using and discard zinc-containing intranasal products (Zicam), due to numerous reports that they may cause a loss of sense of smell (anosmia)."

Sinol is registered as a homeopathic product in the US. Its principal active ingredient is capsaicin, which is derived from the hot pepper plant.

The 2nd generation formulation, Sinol-M, adds a patented mucoadhesive solution (MucoAd) that prolongs the contact between a drug and the mucosa.

Full results of the study will be published in a peer reviewed journal.

Source: ANI
RAS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 9 Reasons Why We Should Practice Kindness
Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
Targeted Screening Program Beneficial for Prostate Cancer Screening
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Allergy Dealing with Pollen Allergy Allergic Rhinitis Watery Eyes Allergy - Symptom Evaluation Nasal Discharge Symptom Evaluation Hay Fever Post-Nasal Drip Spring Allergy Phantosmia (Phantom Smell) 

Most Popular on Medindia

Hearing Loss Calculator Find a Doctor Indian Medical Journals Color Blindness Calculator How to Reduce School Bag Weight - Simple Tips A-Z Drug Brands in India Post-Nasal Drip Find a Hospital Nutam (400mg) (Piracetam) Loram (2 mg) (Lorazepam)

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use